Jenny Lane, co-lead author of the recently published “Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study,” discussed the study and the 2020 journey of hydroxychloroquine during the debut episode…
OHDSI MEETINGS THIS WEEK OHDSI STATEMENT ON COVID-19: OHDSI is committed to doing what it can to support and inform the COVID-19 pandemic response, and will prioritize activities aligned to this effort. As we adjust to the current global situation,…
OHDSI MEETINGS THIS WEEK OHDSI STATEMENT ON COVID-19: OHDSI is committed to doing what it can to support and inform the COVID-19 pandemic response, and will prioritize activities aligned to this effort. As we adjust to the current global situation,…
VIDEO: Co-leads Jennifer Lane, Jamie Weaver discuss the findings, impact and more The combination of hydroxychloroquine (HCQ) and azithromycin (AZM) has been linked to significant cardiovascular risks, including mortality, in the largest safety study ever performed on both HCQ and HCQ+AZM.…
We are pleased to announce the tutorial faculty members for the 2020 OHDSI Symposium, listed in alphabetical order: Rimma Belenkaya, M.A., M.S. Data Modeler/Knowledge Manager Memorial Sloan Kettering Cancer Center I lead the Knowledge Management team at the Memorial Sloan…
The OHDSI community, a proud collaborator with the European Health Data & Evidence Network (EHDEN) since its launch in 2018, celebrates another impressive milestone from EHDEN, which recently certified 10 European SMEs (Small to Medium Enterprise) to map data to the…
The OHDSI community, a proud collaborator with the European Health Data & Evidence Network (EHDEN) since its launch in 2018, celebrates another impressive milestone from EHDEN, which recently certified 10 European SMEs (Small to Medium Enterprise) to map data to the…
OHDSI MEETINGS THIS WEEK OHDSI STATEMENT ON COVID-19: OHDSI is committed to doing what it can to support and inform the COVID-19 pandemic response, and will prioritize activities aligned to this effort. As we adjust to the current global situation,…
An international cohort of OHDSI collaborators obtained a grant from the COVID-19 Therapeutics Accelerator to lead an effort to compare the effectiveness of treatments, including corticosteroids such as dexamethasone, under current evaluation for COVID-19 across an international observational data network.…
OHDSI MEETINGS THIS WEEK OHDSI STATEMENT ON COVID-19: OHDSI is committed to doing what it can to support and inform the COVID-19 pandemic response, and will prioritize activities aligned to this effort. As we adjust to the current global situation,…